Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

Atomwise Stock

Q: How to sell Atomwise stock?

If you hold private company shares of Atomwise - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your Atomwise stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

atomwise.comHealthcare / BioTech & PharmaFounded: 2012Funding to Date: $331.55MM

Atomwise is the developer of first deep learning technology designed for structure-based small molecule drug discovery.

Buy or sell Atomwise stockLearn more about Atomwise IPO

OverviewFinancingsValuation

Enterprise Value

Access Atomwise’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Atomwise.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Izhar Wallach Ph.D

Co-Founder & Chief Technology Officer

Han Lim

Vice President and Global Head of Partnering

Abraham Heifets Ph.D

Co-Founder & Chief Executive Officer

Board Members

Gavin Teo

B Capital Group

Adam Seabrook

B Capital Group

Kiersten Stead Ph.D

Monsanto Growth Ventures

Matthew Ocko

Data Collective

Atomwise stock FAQs

Can you buy Atomwise stock?

As Atomwise is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Atomwise, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Atomwise stock?

To invest in a private company like Atomwise through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Atomwise stock?

Yes, you may be able to sell your Atomwise stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Atomwise stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Atomwise stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is Atomwise a public company?

No, Atomwise is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Atomwise’s stock price?

Atomwise is a privately held company and therefore does not have a public stock price. However, you may access Atomwise’s private market stock price with Forge Data.

What is Atomwise’s stock ticker symbol?

Atomwise does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Venturebeat 08/11/2020

Atomwise raises $123 million to accelerate drug discovery with AI

Atomwise, a company leveraging AI and machine learning to accelerate drug discovery, has raised $123 million in venture capital.

Endpoint News 12/02/2019

Atomwise's X-37 spinout gets $14.5 million to launch AI discovery efforts

The folks behind Atomwise's spinout X-37 like to think in cosmological metaphors, and you can think of their AI drug development model as probes sent into space from a central station. That station just got $14.5 million in Series A funding from DCVC Bio, Alpha Intelligence Capital and Hemi Ventures

Market Screener 03/07/2018

Atomwise Raises $45 Million Series A to Become the Preferred Artificial Intelligence Partner for the Global Pharmaceutical Industry

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.